🇺🇸 FDA
Patent

US 6469027

N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis

expired A61KA61K31/00A61K31/13

Quick answer

US patent 6469027 (N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61K31/13, A61K31/135, A61K31/165